GNMK News and Press, GenMark Diagnostics Inc. From 10/09/20

Medigus (MDGS) +32% on buy out of Amazon Marketplace brands.MicroVision (MVIS) +25%.Just Energy Group (JE) +23%. after PIMCO disclosed 28.9% stake in the company.Xilinx (XLNX) +16% as AMD in advance talks to buy the company.Extreme Networks (EXTR) +17% ...

On a preliminary basis, GenMark Diagnostics (GNMK) expects Q3 revenue of ~$42.6M, up 104% from a year ago. EPlex sales should be ~$38.0M, up 187%.70 ePlex analyzers placed, up 47%.At quarter-end, ePlex Respiratory Pathogen Panel 2 revenue was ~63% of ePlex consumable revenue.Gross margin expa...

RP2 Panel at a Glance GenMark’s ePlex ® Respiratory Pathogen Panel 2 (RP2 Panel) has received Emergency Use Authorization from the FDA. The RP2 Panel provides results in less than two hours for more than 20 viruses and bacteria that cause common respiratory...

CARLSBAD, Calif., Oct. 08, 2020 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ:GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today provided preliminary financial results for the quarter ended September 30, 2020. Third Quarter 2020...

Gainers: AgeX Therapeutics (AGE) +260%. Alphatec (ATEC) +36%. CareDx (CDNA) +19%. Selecta Biosciences (SELB) +16%. Tiziana Life Sciences (TLSA) +13%.Losers: Cytokinetics (CYTK) -44%. Taiwan Liposome (TLC) -18%. IMARA (IMRA) -7%. GenMark Diagnostics (GNMK) -6...

FinancialBuzz.com News Commentary New York, NY (9/23/2020) – As technology evolves to increase productivity and eliminate or reduce human error, several major industries are expected to undergo significant changes. The medical device industry, for example, is expected to enter a ...

Milestone Pharmaceuticals Strengthens Board of Directors with Two New Appointments Canada NewsWire MONTREAL and CHARLOTTE, N.C., Sept. 22, 2020 MONTREAL and CHARLOTTE, N.C., Sept. 22, 2020 /CNW/ -- Milestone Pharmaceuticals Inc. (Nasdaq: MIST)...

Investment Thesis Enzo Biochem, Inc. ( ENZ ) is a vertically integrated life sciences company focusing on developing unique diagnostic platform technologies. Specific to the outbreak of COVID-19, ENZ also provides both molecular and serology tests in New York, New Jersey, and Connecticut. ...

Molecular syndromic test for COVID-19, influenza and other common respiratory pathogens helps health care professionals prepare for flu season RP2 Panel at a Glance GenMark’s ePlex® Respiratory Pathogen Panel 2 (RP2) has achieved CE mark. RP2 provides results in l...

Several stocks of companies that make COVID-19 diagnostic tests were sinking on Thursday following big news from Abbott Laboratories (NYSE: ABT) on Wednesday evening. Abbott announced that it received FDA emergency use authorization (EUA) for a COVID-19 antibody test that costs $5 and provi...